Targeting Production of Reactive Oxygen Species as an Anticancer Strategy

Area of Science:

• Oncology and Molecular Biology
• Cellular Biology
• Biochemistry

Background:

• Cancer is a leading global cause of death, driving research into novel therapeutic strategies.
• Cancer cells exhibit altered cellular redox balance, characterized by elevated oxidizing agents due to hypermetabolism and genetic instability.
• Oxidative stress, involving free radicals, plays a dual role in cellular signaling and disease pathogenesis, including cancer.

Purpose of the Study:

• To review the role of oxidative stress in the mechanisms of action of anticancer agents.
• To explore the therapeutic potential of targeting the differential cellular redox balance between normal and cancer cells.
• To examine approved and experimental drugs that modulate cellular redox state.

Main Methods:

• Literature review of anticancer agents and their impact on cellular redox balance.
• Analysis of pro-oxidant and antioxidant mechanisms of drug action.
• Discussion of the significance of redox modulation in anticancer drug efficacy.

Main Results:

• Anticancer agents can exert their effects by altering the cellular redox state.
• Drugs can act through either pro-oxidant or antioxidant mechanisms to combat cancer.
• The differential redox balance between cancer and normal cells presents a viable therapeutic target.

Conclusions:

• Modulating cellular redox balance is a crucial aspect of anticancer therapy.
• Understanding the redox mechanisms of drugs enhances their therapeutic application.
• Targeting oxidative stress offers a promising avenue for developing novel and effective anticancer treatments.